Article
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination
17 Jul 2024
Abstract excerpt
Glioblastoma (GBM) cells exhibit aberrant proliferative abilities and resistance to conventional therapies. However, the mechanisms underlying these malignant phenotypes are poorly understood. In this study, we identified ubiquitin-conjugating enzyme E2D1 (UBE2D1) as a crucial stimulator of GBM development. It is highly expressed in GBM and closely associated with poor prognosis in patients with GBM. UBE2D1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
